0 CHECKOUT

PRODUCT FILTERS

REGION

78
65
62
61
10

COUNTRY

60
4
4
2
1

CATEGORIES

  • 154
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

69
164
166
236

PUBLISHED

4
11
38
236

PRODUCT TYPE

137
74
9
6
5
2
2
1

Search for: "PharmaNet Development Group, Inc."

PharmaNet Development Group Inc.

This PrivCo private company report on PharmaNet Development Group Inc. provides a detailed PharmaNet Development Group Inc. company profile, consisting of PharmaNet Development Group Inc. financials,...

Published:  February 2016
Price: 

PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries....

Published:  November 2015
Price: 

PharmaNet Development Group, Inc. (Formerly SFBC International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

Published:  August 2015
Price:  From

PharmaNet Development Group Inc. - Company Capsule

Synopsis ICD Research's "PharmaNet Development Group Inc. - Company Capsule" contains a company overview, key facts, key employees, products and services, locations and subsidiaries as well as financial...

Published:  November 2011
Price:  From

PharmaNet Development Group Inc. Jul 10

Abstract PharmaNet is a solid mid-size player in the contract research industry and has an international presence; and The company has defensible niches in select therapeutic classes. PharmaNet is...

Published:  July 2010
Price: 

Summary: PharmaNet Development Group Inc. Jan 11

Abstract The speculative grade ratings on Princeton, N.J.-based PharmaNet Development Group Inc. reflect the sponsor-owned company's aggressive financial risk profile and PharmaNet's need to continue...

Published:  January 2011
Price: 

Recovery Report: PharmaNet Development Group Inc.'s Recovery Rating Profile Apr 11

Abstract Standard and Poor's Rating Services is reviewing recovery ratings and issue level debt ratings on Princeton, N.J.-based drug development services company, PharmaNet Development Group Inc....

Published:  April 2011
Price: 

Research Update: PharmaNet Development Group Inc.'s Ratings Withdrawn Following Acquisition Jul 11

Abstract On July 27, 2011, Standard & Poor's Ratings Services withdrew its ratings on Princeton, N.J.-based contract pharmaceutical research organization PharmaNet Development Group Inc., following...

Published:  July 2011
Price: 

PharmaNet Development Group Inc.'s Ratings Withdrawn Following Acquisition Jul 11

Abstract TORONTO (Standard & Poor's) July 27, 2011--Standard & Poor's Ratings Services said today that it withdrew its ratings on Princeton, N.J.-based contract pharmaceutical research organization...

Published:  July 2011
Price: 

Summary: PharmaNet Development Group Inc. Jul 10

Abstract The speculative grade ratings on Princeton, N.J.-based PharmaNet Development Group Inc. reflect the sponsor-owned company's aggressive financial risk profile and PharmaNet's need to continue...

Published:  July 2010
Price: 

PharmaNet Development Group Inc. Corporate Credit Rated 'B+'; Rating Outlook Is Stable Mar 10

Abstract After over one year of ownership, the financial sponsor, JLL Partners, is considering a debt-financed dividend from Princeton, N.J.-based PharmaNet Development Group Inc., one of larger players...

Published:  March 2010
Price: 

Research Update: PharmaNet Development Group Inc. Corporate Credit Rated 'B+'; Outlook Is Stable Mar 10

Abstract After over one year of ownership, the financial sponsor, JLL Partners, is considering a debt-financed dividend from Princeton, N.J.-based PharmaNet Development Group Inc., one of larger players...

Published:  March 2010
Price: 

Catalent Pharma Solutions, Inc. - Strategy and SWOT Report

Catalent Pharma Solutions, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

Published:  April 2014
Price:  From

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

Published:  June 2015
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

The Global Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

Published:  February 2016
Price:  From

Nanotechnology - Global Strategic Business Report

This report analyzes the worldwide markets for Nanotechnology in US$ Billion by the following End-Use Sectors: Chemicals, Automotive, Aerospace & Defense, Semiconductors & Electronics, Pharma & Healthcare,...

Published:  September 2014
Price:  From

PharmaNet Development Group Inc Oct 06

Abstract Continued strong macro trends for the outsourced pharmaceutical research industry; Company's relatively strong cash flow generation; and Relatively low cost of debt. Company's short record...

Published:  October 2006
Price: 

PharmaNet Development Group Inc Dec 07

Abstract Continued strong macro-level trends for the outsourced pharmaceutical research industry; Stabilization of operations after business difficulties of late-2005; and Relatively low cost of debt....

Published:  December 2007
Price: 

Global Market Study on Vitamin Supplements: Vitamin D Segment to Witness Highest Growth by 2020

With increasing age, it is difficult for the body to optimally absorb the required nutrients from food. Furthermore, loss of appetite is also a common problem among the geriatric population. Elderly...

Published:  February 2015
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.